Chromatin as a Target for the DNA-Binding Anticancer Drugs

Chemotherapy has been a major approach to treat cancer. Both constituents of chromatin, chromosomal DNA and the associated chromosomal histone proteins are the molecular targets of the anticancer drugs. Small DNA binding ligands, which inhibit enzymatic processes with DNA substrate, are well known i...

Descripción completa

Detalles Bibliográficos
Autores principales: Majumder, Parijat, Pradhan, Suman K., Devi, Pukhrambam Grihanjali, Pal, Sudipta, Dasgupta, Dipak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121056/
https://www.ncbi.nlm.nih.gov/pubmed/17484128
http://dx.doi.org/10.1007/1-4020-5466-1_8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121056/
https://www.ncbi.nlm.nih.gov/pubmed/17484128
http://dx.doi.org/10.1007/1-4020-5466-1_8

Ejemplares similares